Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active player

Oncogene (2026)Cite this article

Subjects

Abstract

Cancer remains a leading cause of human mortality worldwide, imposing a substantial public health burden. A deep understanding of the tumor microenvironment (TME) is essential for improving cancer care. Erythroid progenitor cells (EPCs) were traditionally viewed solely as intermediates in erythropoiesis; however, growing evidence indicates their active involvement in cancer progression and immune evasion. Research on EPCs increasingly utilizes omics sequencing technologies. Multi-omics strategies in particular enable in-depth investigation of the functional mechanisms of EPCs and their interactions with tumor and immune cells. This review examines various omics methodologies applied to EPCs from an oncology perspective, including transcriptomics, proteomics, epigenomics, and metabolomics, while critically assessing the advantages and limitations of each approach. Furthermore, it synthesizes how the integration of multiple omics technologies provides a more comprehensive view of EPC biology, particularly through complementary data modalities. This review also discusses artificial intelligence (AI)-powered multi-omics integration strategies and explore the translational potential of EPC-focused research in advancing cancer therapeutics from bench to bedside.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Overview of multi-omics for decoding EPCs in cancer.
Fig. 2: EPCs in physiological and cancerous contexts.
Fig. 3: Decoding the origins and heterogeneity of EPCs in cancer through multi-omics strategies.
Fig. 4: AI-powered multi-omics integrative analysis of EPCs.

Similar content being viewed by others

References

  1. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10–45.

    PubMed  PubMed Central  Google Scholar 

  2. Filho AM, Laversanne M, Ferlay J, Colombet M, Pineros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156:1336–46.

    Article  PubMed  Google Scholar 

  3. Arafat Hossain M. A comprehensive review of immune checkpoint inhibitors for cancer treatment. Int Immunopharmacol. 2024;143:113365.

    Article  CAS  PubMed  Google Scholar 

  4. Wagle NS, Nogueira L, Devasia TP, Mariotto AB, Yabroff KR, Islami F, et al. Cancer treatment and survivorship statistics, 2025. CA Cancer J Clin. 2025;75:308–40.

    PubMed  PubMed Central  Google Scholar 

  5. Zhang C, Zhang C, Wang H. Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions. Cancer Lett. 2023;562:216182.

    Article  CAS  PubMed  Google Scholar 

  6. Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther. 2021;6:72.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Li ZZ, Zhou K, Wu Q, Liu B, Bu LL. Lymph node metastasis in cancer: clearing the clouds to see the dawn. Crit Rev Oncol Hematol. 2024;204:104536.

    Article  PubMed  Google Scholar 

  8. Bader JE, Voss K, Rathmell JC. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell. 2020;78:1019–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Li ZZ, Wu TF, Sun ZJ. Harnessing cuproptosis resistance to advance cancer therapeutics. Apoptosis. 2026;31:50.

  10. Li SR, Wu ZZ, Yu HJ, Sun ZJ. Targeting erythroid progenitor cells for cancer immunotherapy. Int J Cancer. 2024;155:1928–38.

    Article  CAS  PubMed  Google Scholar 

  11. He X, Liu X, Zuo F, Shi H, Jing J. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol. 2023;88:187–200.

    Article  CAS  PubMed  Google Scholar 

  12. Szeto GL, Finley SD. Integrative approaches to cancer immunotherapy. Trends Cancer. 2019;5:400–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Donisi C, Pretta A, Pusceddu V, Ziranu P, Lai E, Puzzoni M, et al. Immunotherapy and cancer: the multi-omics perspective. Int J Mol Sci. 2024;25:3563.

  14. Hernandez-Lemus E, Ochoa S. Methods for multi-omic data integration in cancer research. Front Genet. 2024;15:1425456.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wang YY, Wu ZZ, Huang CF, Sun ZJ. Tumor-host colluding through erythroid progenitor cells: Mechanisms and opportunities. Cancer Lett. 2023;563:216193.

    Article  CAS  PubMed  Google Scholar 

  16. Tang P, Wang H. Regulation of erythropoiesis: emerging concepts and therapeutic implications. Hematology. 2023;28:2250645.

    Article  PubMed  Google Scholar 

  17. Schippel N, Sharma S. Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage. Exp Hematol. 2023;123:1–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Nandakumar SK, Ulirsch JC, Sankaran VG. Advances in understanding erythropoiesis: evolving perspectives. Br J Haematol. 2016;173:206–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Hewitt KJ, Johnson KD, Gao X, Keles S, Bresnick EH. The hematopoietic stem and progenitor cell cistrome: GATA factor-dependent Cis-regulatory mechanisms. Curr Top Dev Biol. 2016;118:45–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Sincennes MC, Humbert M, Grondin B, Lisi V, Veiga DF, Haman A, et al. The LMO2 oncogene regulates DNA replication in hematopoietic cells. Proc Natl Acad Sci USA. 2016;113:1393–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Wang C, Hu M, Yu K, Liu W, Hu A, Kuang Y, et al. An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation. Mol Med Rep. 2024;29:107.

  22. Adlung L, Stapor P, Tonsing C, Schmiester L, Schwarzmuller LE, Postawa L, et al. Cell-to-cell variability in JAK2/STAT5 pathway components and cytoplasmic volumes defines survival threshold in erythroid progenitor cells. Cell Rep. 2021;36:109507.

    Article  CAS  PubMed  Google Scholar 

  23. Feng Y, Borosha S, Ratri A, Lee EB, Wang H, Fields TA, et al. DOT1L methyltransferase regulates calcium influx in erythroid progenitor cells in response to erythropoietin. Int J Mol Sci. 2022;23:5137.

  24. Li J, Hale J, Bhagia P, Xue F, Chen L, Jaffray J, et al. Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. Blood. 2014;124:3636–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Barisas DAG, Choi K. Extramedullary hematopoiesis in cancer. Exp Mol Med. 2024;56:549–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zhao L, He R, Long H, Guo B, Jia Q, Qin D, et al. Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells. Nat Med. 2018;24:1536–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen Z, Cheng X, Yang L, Cheng X, Zhu B, Long H. Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity. Cancer Biol Med. 2023;20:477–82.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Li ZZ, Su XY, Zhou CK, Li SR, Sun ZJ. Epigenetic reprogramming of erythroid progenitor cells: insights for enhancing cancer immunotherapy. Int J Biol Sci. 2026;22:1997–2011.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Long H, Jia Q, Wang L, Fang W, Wang Z, Jiang T, et al. Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy. Cancer Cell. 2022;40:674–693 e677.

    Article  CAS  PubMed  Google Scholar 

  30. Wu ZZ, Deng WW, Zhu SW, Wang WD, Wang S, Yang QC, et al. Erythroid progenitor cell-mediated spleen-tumor interaction deteriorates cancer immunity. Proc Natl Acad Sci USA. 2025;122:e2417473122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-induced generation of splenic erythroblast-like Ter-cells promotes tumor progression. Cell. 2018;173:634–648.

    Article  CAS  PubMed  Google Scholar 

  32. Mamand DR, Bazaz S, Mohammad DK, Liang X, Pavlova S, Mim C, et al. Extracellular vesicles originating from melanoma cells promote dysregulation in haematopoiesis as a component of cancer immunoediting. J Extracell Vesicles. 2024;13:e12471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Mo WT, Huang CF, Sun ZJ. Erythroid progenitor cell modulates cancer immunity: insights and implications. Biochim Biophys Acta Rev Cancer. 2024;1879:189209.

    Article  CAS  PubMed  Google Scholar 

  34. Ediriwickrema A, Nakauchi Y, Fan AC, Kohnke T, Hu X, Luca BA, et al. A single-cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesis. Cell Rep. 2025;44:116236.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Song Q, Liu L. Single-cell RNA-Seq technologies and computational analysis tools: application in cancer research. Methods Mol Biol. 2022;2413:245–55.

    Article  CAS  PubMed  Google Scholar 

  36. Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, et al. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 2021;40:81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Wen JY, Li X, Chen JN, Chen J, Zhang JY, Du Y, et al. CD45(-) erythroid progenitor cells promote lymph node metastasis in gastric cancer by inducing a hybrid epithelial/mesenchymal state in lymphatic endothelial cells. Gastric Cancer. 2023;26:918–33.

    Article  CAS  PubMed  Google Scholar 

  38. Chang X, Zheng Y, Xu K. Single-cell RNA sequencing: technological progress and biomedical application in cancer research. Mol Biotechnol. 2024;66:1497–519.

    Article  CAS  PubMed  Google Scholar 

  39. Conboy JG. RNA splicing during terminal erythropoiesis. Curr Opin Hematol. 2017;24:215–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Tusi BK, Wolock SL, Weinreb C, Hwang Y, Hidalgo D, Zilionis R, et al. Population snapshots predict early haematopoietic and erythroid hierarchies. Nature. 2018;555:54–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Xu C, He J, Wang H, Zhang Y, Wu J, Zhao L, et al. Single-cell transcriptomic analysis identifies an immune-prone population in erythroid precursors during human ontogenesis. Nat Immunol. 2022;23:1109–20.

    Article  CAS  PubMed  Google Scholar 

  42. Weiler P, Van den Berge K, Street K, Tiberi S. A guide to trajectory inference and RNA velocity. Methods Mol Biol. 2023;2584:269–92.

    Article  CAS  PubMed  Google Scholar 

  43. Ranzoni AM, Tangherloni A, Berest I, Riva SG, Myers B, Strzelecka PM, et al. Integrative single-cell RNA-Seq and ATAC-seq analysis of human developmental hematopoiesis. Cell Stem Cell. 2021;28:472–87.

    Article  CAS  PubMed  Google Scholar 

  44. Furtwangler B, Uresin N, Richter S, Schuster MB, Barmpouri D, Holze H, et al. Mapping early human blood cell differentiation using single-cell proteomics and transcriptomics. Science. 2025;390:eadr8785.

    Article  CAS  PubMed  Google Scholar 

  45. Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32:381–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Saelens W, Cannoodt R, Todorov H, Saeys Y. A comparison of single-cell trajectory inference methods. Nat Biotechnol. 2019;37:547–54.

    Article  CAS  PubMed  Google Scholar 

  47. Christodoulou MI, Zaravinos A single-cell analysis in immuno-oncology. Int J Mol Sci. 2023;24:8422.

  48. Bai Z, Su G, Fan R. Single-cell analysis technologies for immuno-oncology research: from mechanistic delineation to biomarker discovery. Genomics Proteom Bioinforma. 2021;19:191–207.

    Article  CAS  Google Scholar 

  49. Hou X, Wang YL, Shi W, Hu W, Zeng Z, Liu J, et al. Multiplexed analysis of gene expression and chromatin accessibility of human umbilical cord blood using scRNA-Seq and scATAC-Seq. Mol Immunol. 2022;152:207–14.

    Article  CAS  PubMed  Google Scholar 

  50. Luo C, Rivkin A, Zhou J, Sandoval JP, Kurihara L, Lucero J, et al. Robust single-cell DNA methylome profiling with snmC-seq2. Nat Commun. 2018;9:3824.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Nam AS, Dusaj N, Izzo F, Murali R, Myers RM, Mouhieddine TH, et al. Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation. Nat Genet. 2022;54:1514–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Kaya-Okur HS, Janssens DH, Henikoff JG, Ahmad K, Henikoff S. Efficient low-cost chromatin profiling with CUT&Tag. Nat Protoc. 2020;15:3264–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Kaya-Okur HS, Wu SJ, Codomo CA, Pledger ES, Bryson TD, Henikoff JG, et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat Commun. 2019;10:1930.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Deng Y, Bartosovic M, Kukanja P, Zhang D, Liu Y, Su G, et al. Spatial-CUT&Tag: Spatially resolved chromatin modification profiling at the cellular level. Science. 2022;375:681–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Wu SJ, Furlan SN, Mihalas AB, Kaya-Okur HS, Feroze AH, Emerson SN, et al. Single-cell CUT&Tag analysis of chromatin modifications in differentiation and tumor progression. Nat Biotechnol. 2021;39:819–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Park PJ. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet. 2009;10:669–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Chen Y, Huo D, Meng Y, Zhang J, Huang M, Luo Q, et al. BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesis. J Hematol Oncol. 2025;18:67.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Gautier EF, Ducamp S, Leduc M, Salnot V, Guillonneau F, Dussiot M, et al. Comprehensive proteomic analysis of human erythropoiesis. Cell Rep. 2016;16:1470–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Brand M, Ranish JA. Proteomic/transcriptomic analysis of erythropoiesis. Curr Opin Hematol. 2021;28:150–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Grzywa TM, Justyniarska M, Nowis D, Golab J. Tumor immune evasion induced by dysregulation of erythroid progenitor cells development. Cancers. 2021;13:870.

  61. Hou Y, Liang HL, Yu X, Liu Z, Cao X, Rao E, et al. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity. Sci Transl Med. 2021;13:130.

  62. Sasaki S, Inoguchi T, Muta K, Abe Y, Zhang M, Hiasa K, et al. Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells. Am J Physiol Heart Circ Physiol. 2007;292:H657–665.

    Article  CAS  PubMed  Google Scholar 

  63. Karayel O, Xu P, Bludau I, Velan Bhoopalan S, Yao Y, Ana Rita FC, et al. Integrative proteomics reveals principles of dynamic phosphosignaling networks in human erythropoiesis. Mol Syst Biol. 2020;16:e9813.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Danzi F, Pacchiana R, Mafficini A, Scupoli MT, Scarpa A, Donadelli M, et al. To metabolomics and beyond: a technological portfolio to investigate cancer metabolism. Signal Transduct Target Ther. 2023;8:137.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin. 2021;71:333–58.

    PubMed  PubMed Central  Google Scholar 

  66. Fan X, Peng H, Wang X, Sun Y, Dong Y, Zhou J, et al. Tumor-associated CD8(+)T cell tolerance induced by erythroid progenitor cells. Front Immunol. 2024;15:1381919.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Argelaguet R, Arnol D, Bredikhin D, Deloro Y, Velten B, Marioni JC, et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 2020;21:111.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, Aittomaki V, et al. Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Med. 2010;2:65.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Schmidt D, Endres C, Hoefflin R, Andrieux G, Zwick M, Karantzelis N, et al. Oncogenic calreticulin induces immune escape by stimulating TGFbeta expression and regulatory T-cell expansion in the bone marrow microenvironment. Cancer Res. 2024;84:2985–3003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Sarachakov A, Varlamova A, Svekolkin V, Polyakova M, Valencia I, Unkenholz C, et al. Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodeling. Blood. 2023;142:2282–95.

    Article  CAS  PubMed  Google Scholar 

  71. Jackson C, Cherry C, Bom S, Dykema AG, Wang R, Thompson E, et al. Distinct myeloid-derived suppressor cell populations in human glioblastoma. Science. 2025;387:eabm5214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Han X, Wang B, Situ C, Qi Y, Zhu H, Li Y, et al. scapGNN: A graph neural network-based framework for active pathway and gene module inference from single-cell multi-omics data. PLoS Biol. 2023;21:e3002369.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee GR, et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science. 2021;373:871–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Baek M, McHugh R, Anishchenko I, Jiang H, Baker D, DiMaio F. Accurate prediction of protein-nucleic acid complexes using RoseTTAFoldNA. Nat Methods. 2024;21:117–21.

    Article  CAS  PubMed  Google Scholar 

  75. Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8–17.

    Article  CAS  PubMed  Google Scholar 

  76. Ahmed R, Augustine R, Valera E, Ganguli A, Mesaeli N, Ahmad IS, et al. Spatial mapping of cancer tissues by OMICS technologies. Biochim Biophys Acta Rev Cancer. 2022;1877:188663.

    Article  CAS  PubMed  Google Scholar 

  77. Zhou WM, Yan YY, Guo QR, Ji H, Wang H, Xu TT, et al. Microfluidics applications for high-throughput single cell sequencing. J Nanobiotechnol. 2021;19:312.

    Article  CAS  Google Scholar 

  78. Li ZZ, Wei LY, Cao LM, Wang GR, Luo HY, Zhou K, et al. Emerging roles of microfluidics in oral cancer research and clinical translation. Mater Today Bio. 2026;37:102801.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Lin S, Liu Y, Zhang M, Xu X, Chen Y, Zhang H, et al. Microfluidic single-cell transcriptomics: moving towards multimodal and spatiotemporal omics. Lab Chip. 2021;21:3829–49.

    Article  CAS  PubMed  Google Scholar 

  80. Tyson JJ, Chen K, Novak B. Network dynamics and cell physiology. Nat Rev Mol Cell Biol. 2001;2:908–16.

    Article  CAS  PubMed  Google Scholar 

  81. Stahlberg EA, Abdel-Rahman M, Aguilar B, Asadpoure A, Beckman RA, Borkon LL, et al. Exploring approaches for predictive cancer patient digital twins: opportunities for collaboration and innovation. Front Digit Health. 2022;4:1007784.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Bjornsson B, Borrebaeck C, Elander N, Gasslander T, Gawel DR, Gustafsson M, et al. Digital twins to personalize medicine. Genome Med. 2019;12:4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (82273202); the Fundamental Research Funds for the Central Universities (2042022dx0003).

Author information

Author notes

  1. These authors contributed equally: Zi-Zhan Li, Cheng-Ke Zhou.

Authors and Affiliations

  1. State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China

    Zi-Zhan Li, Cheng-Ke Zhou & Zhi-Jun Sun

Authors
  1. Zi-Zhan Li
    View author publications

    Search author on:PubMed Google Scholar

  2. Cheng-Ke Zhou
    View author publications

    Search author on:PubMed Google Scholar

  3. Zhi-Jun Sun
    View author publications

    Search author on:PubMed Google Scholar

Contributions

Zi-Zhan Li: Writing – review & editing, Writing – original draft, Visualization, Validation, Software, Resources, Investigation. Cheng-Ke Zhou: Writing – original draft, Visualization, Software, Conceptualization, Writing – review & editing. Zhi-Jun Sun: Writing – review & editing, Conceptualization, Supervision, Investigation, Funding acquisition.

Corresponding author

Correspondence to Zhi-Jun Sun.

Ethics declarations

Competing interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, ZZ., Zhou, CK. & Sun, ZJ. Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active player. Oncogene (2026). https://doi.org/10.1038/s41388-026-03758-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41388-026-03758-0

Search

Advanced search

Quick links